Whalesbook
The board of Raaj Medisafe India Limited has officially approved the preferential issuance of 32,75,000 equity shares. The issue price is set at ₹55 per share, representing a premium of ₹45 over the ₹10 face value. This transaction is anticipated to bring in cash totaling approximately ₹17.99 crore. BSE Limited has provided its preliminary approval for this share issuance.
Impact of the Fundraise
This preferential allotment will increase the company's total equity share capital. The fresh capital is intended to support business expansion, reduce debt, or bolster working capital. However, it will also lead to dilution for existing shareholders, as the total number of outstanding shares will increase.
Company Background and Recent Moves
Raaj Medisafe India Limited, incorporated in 1985 and formerly known as Manoj Surgical Industries, operates in the manufacturing of plastic bottles, caps, plugs, and hygiene products within the Plastic and Hygiene segments. The company has demonstrated a strong financial recovery and growth trajectory from FY2021 to FY2025, marked by rising net sales and a shift from loss to profitability. In a significant strategic development, Raaj Medisafe announced plans in December 2025 to acquire Fabrizo Industries Private Limited, signalling an expansion into the alcobev packaging sector.
Key Risks for Investors
Investors should closely monitor the potential dilution of their ownership percentage resulting from the increased share count. A critical factor will be the effective utilization of the ₹17.99 crore raised to drive business growth or achieve strategic goals.
Industry Peers
Raaj Medisafe operates in the packaging and plastic products sector. Competitors include larger entities such as Uflex Ltd, Nilkamal Ltd, and Time Technoplast Ltd, alongside specialized firms like Kanpur Plastipack Ltd and Bulkcorp International Ltd. These companies offer various plastic packaging solutions, differing in scale and specific product focus.
Investor Watchlist
Looking ahead, investors will want to track the final listing approval of the newly allotted shares by the stock exchange. Monitoring how the company deploys the raised funds and observing the progress of the proposed Fabrizo Industries Private Limited acquisition will also be key. Any further disclosures concerning SEBI regulations on preferential issues should also be noted.